Literature DB >> 9924810

Conversion of native oligomeric to a modified monomeric form of human C-reactive protein.

J J Kresl1, L A Potempa, B E Anderson.   

Abstract

C-reactive protein (CRP) is a pentameric oligoprotein composed of identical 23 kD subunits which can be modified by urea-chelation treatment to a form resembling the free subunit termed modified CRP (mCRP). mCRP has distinct physicochemical, antigenic, and biologic activities compared to CRP. The conditions under which CRP is converted to mCRP, and the molecular forms in the transition, are important to better understand the distinct properties of mCRP and to determine if the subunit form can convert back to the pentameric native CRP form. This study characterized the antigenic and conformational changes associated with the interconversion of CRP and mCRP. The rate of dissociation of CRP protomers into individual subunits by treatment in 8 M urea-10 mM EDTA solution was rapid and complete in 2 min as assayed by an enzyme-linked immunofiltration assay using monoclonal antibodies specific to the mCRP. Attempts to reconstitute pentameric CRP from mCRP under renaturation conditions were unsuccessful, resulting in a protein retaining exclusively mCRP characteristics. Using two-dimensional urea gradient gel electrophoresis, partial rapid unfolding of the pentamer occurred above 3 M urea, a subunit dissociation at 6 M urea, and further subunit unfolding at 6-8 M urea concentrations. The urea gradient electrophoresis results suggest that there are only two predominant conformational states occurring at each urea transition concentration. Using the same urea gradient electrophoresis conditions mCRP migrated as a single molecular form at all urea concentrations showing no evidence for reassociation to pentameric CRP or other aggregate form. The results of this study show a molecular conversion for an oligomeric protein (CRP) to monomeric subunits (mCRP) having rapid forward transition kinetics in 8 M urea plus chelator with negligible reversibility.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924810     DOI: 10.1016/s1357-2725(98)00078-8

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  20 in total

1.  Studies on the interactions between C-reactive protein and complement proteins.

Authors:  Adrienn Bíró; Zita Rovó; Diana Papp; László Cervenak; Lilian Varga; George Füst; Nicole M Thielens; Gérard J Arlaud; Zoltán Prohászka
Journal:  Immunology       Date:  2007-01-18       Impact factor: 7.397

2.  Linking inflammation and thrombosis: Role of C-reactive protein.

Authors:  William P Fay
Journal:  World J Cardiol       Date:  2010-11-26

Review 3.  Regulation of C-reactive protein conformation in inflammation.

Authors:  ZhenYu Yao; Yanmin Zhang; HaiBin Wu
Journal:  Inflamm Res       Date:  2019-07-16       Impact factor: 4.575

4.  Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

Authors:  Sanna Taskinen; Petri T Kovanen; Hanna Jarva; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

5.  Human pentraxin 3 binds to the complement regulator c4b-binding protein.

Authors:  Anne Braunschweig; Mihály Józsi
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

Review 6.  Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes.

Authors:  J R Thiele; J Zeller; H Bannasch; G B Stark; K Peter; S U Eisenhardt
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

7.  Obesity associated molecular forms of C-reactive protein in human.

Authors:  Bela F Asztalos; Michael S Horan; Katalin V Horvath; Ann Y McDermott; Naga P Chalasani; Ernst J Schaefer
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

8.  Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.

Authors:  Christopher Sjöwall; Anders A Bengtsson; Gunnar Sturfelt; Thomas Skogh
Journal:  Arthritis Res Ther       Date:  2003-12-05       Impact factor: 5.156

9.  Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease.

Authors:  Marina Mesquida; Blanca Molins; Victor Llorenç; Maite Sainz de la Maza; María Victoria Hernandez; Gerard Espinosa; Alfredo Adán
Journal:  Mediators Inflamm       Date:  2014-06-08       Impact factor: 4.711

10.  Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

Authors:  Satu Sinikka Pesickova; Romana Rysava; Martin Lenicek; Libor Vitek; Eliska Potlukova; Zdenka Hruskova; Eva Jancova; Eva Honsova; Jakub Zavada; Marten Trendelenburg; Vladimir Tesar
Journal:  Arthritis Res Ther       Date:  2015-12-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.